Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlong Tablet for Mammary Gland Hyperplasia (Qi Stagnation and Blood Stasis)
CTR20132437Phase 3Completed
- Sponsor
- Enwei Pharmaceutical
- Start
- Feb 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Danlong in breast hyperplasia, sponsored by Enwei Pharmaceutical. Started Feb 2014; status: completed.
02
Drugs
Danlong
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on CTR20132437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132437.